Table 1 Socio-demographic and clinical characteristics of the study subjects (n = 192)
Male gender | 122 (63.5) |
|---|---|
Age, y* | 68.1 (8.5) |
Employed full time or part-time | 77 (40.1) |
Post compulsory education or above | 155 (80.7) |
Married or living with partner | 151 (78.6) |
Karnofsky Performance status | Â |
80-100 | 166 (86.5) |
Comorbid liver disease | Â |
Hepatitis C virus | 126 (65.6) |
Hepatitis B virus | 38 (19.8) |
Other or unknown | 28 (14.6) |
Child-Pugh class | Â |
A | 127 (66.1) |
B | 53 (27.6) |
C | 12 (6.3) |
Cancer stage | Â |
Stage I / II | 161 (83.9) |
Stage III / IV | 31 (16.1) |
Time since diagnosis, month* | 39.6 (34.5) |
Past medical history†|  |
Hepatectomy | 48 (25.0) |
Percutaneous ablation | 137 (71.4) |
Chemoembolization | 64 (33.3) |
Systemic therapy | 1 (0.5) |
No medical history | 13 (6.8) |